Literature DB >> 10651256

Worldwide increase in incidence of Type I diabetes--the analysis of the data on published incidence trends.

P Onkamo1, S Väänänen, M Karvonen, J Tuomilehto.   

Abstract

AIMS/HYPOTHESIS: Several reports on the incidence of Type I (insulin-dependent) diabetes mellitus have suggested that the incidence is increasing. The aim of this study was to find out whether the incidence is increasing globally or restricted to a selected populations only and to estimate the magnitude of the change in incidence.
METHODS: During 1960 to 1996 37 studies in 27 countries were carried out. To fulfil the inclusion criteria the study periods ranged from 8-32 years. The temporal trend was fitted by linear regression, with the logarithm of the age-standardized incidence as the dependent variable and the calendar year as the independent variable. Then, the regression coefficient (x 100%) is approximately the average relative increase in incidence per year (as percentage).
RESULTS: Results from the pooled data from all 37 populations showed that the overall increase in incidence was 3.0% per year (95% CI 2.6; 3.3, p = 0.0001). The statistically significant increase was found in 24 of 37 populations including all high incidence (> 14.6 per 100000 a year) populations. The relative increase was, however, steeper in the populations with a lower incidence. The correlation between logarithm of the incidence and the increase in incidence was r = -0.56, p = 0.0004. CONCLUSION/
INTERPRETATION: The incidence of Type I diabetes is increasing worldwide both in low and high incidence populations. By the year 2010 the incidence will be 50 per 100000 a year in Finland and also in many other populations it will exceed 30 per 100000 a year.

Entities:  

Mesh:

Year:  1999        PMID: 10651256     DOI: 10.1007/s001250051309

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  182 in total

1.  Type 2 diabetes in children.

Authors:  A Fagot-Campagna; K M Narayan; G Imperatore
Journal:  BMJ       Date:  2001-02-17

Review 2.  The Sardinian way to type 1 diabetes.

Authors:  Marco Songini; Cira Lombardo
Journal:  J Diabetes Sci Technol       Date:  2010-09-01

Review 3.  Interventions to improve the management of diabetes mellitus in primary care, outpatient and community settings.

Authors:  C M Renders; G D Valk; S Griffin; E H Wagner; J T Eijk; W J Assendelft
Journal:  Cochrane Database Syst Rev       Date:  2001

4.  Health-related quality of life in type 1 diabetes without or with symptoms of long-term complications.

Authors:  J Hahl; H Hämäläinen; H Sintonen; T Simell; S Arinen; O Simell
Journal:  Qual Life Res       Date:  2002-08       Impact factor: 4.147

Review 5.  Type 1 diabetes: recent developments.

Authors:  Devasenan Devendra; Edwin Liu; George S Eisenbarth
Journal:  BMJ       Date:  2004-03-27

6.  Novel analytical methods applied to type 1 diabetes genome-scan data.

Authors:  Flemming Pociot; Allan E Karlsen; Claus B Pedersen; Mogens Aalund; Jørn Nerup
Journal:  Am J Hum Genet       Date:  2004-03-11       Impact factor: 11.025

7.  Descriptive epidemiology of type 1 diabetes--is it still in?

Authors:  M Knip
Journal:  Diabetologia       Date:  2012-03-09       Impact factor: 10.122

Review 8.  Understanding type 1 diabetes through genetics: advances and prospects.

Authors:  Constantin Polychronakos; Quan Li
Journal:  Nat Rev Genet       Date:  2011-10-18       Impact factor: 53.242

9.  Differential expression of GLUT2 in pancreatic islets and kidneys of New and Old World nonhuman primates.

Authors:  Joshua Kramer; Elisabeth Ludlage Moeller; Audra Hachey; Keith G Mansfield; Lynn M Wachtman
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-12-10       Impact factor: 3.619

10.  Parent perspectives of diabetes management in schools.

Authors:  Farrah Jacquez; Stacey Stout; Rose Alvarez-Salvat; Michelle Fernandez; Manuela Villa; Janine Sanchez; Margaret Eidson; Robin Nemery; Alan Delamater
Journal:  Diabetes Educ       Date:  2008 Nov-Dec       Impact factor: 2.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.